FYI: Just when we thought the biotechnology rally was taking a breather, many biotech stocks got a second wind — and that’s good news for growth investors. Gaining exposure to the biotechnology sector makes sense for most investors — but the big question isn’t whether you play the biotech boom, but how you play it.
Let’s be clear: biotech stocks are the epitome of volatile, high-beta securities. While the NASDAQ Biotechnology Index is up 18% year-to-date, it has been a wild ride: up 21% from January to late February, down 21% from February to mid-April and up 24% since then.
Regards,
Ted
http://investorplace.com/2014/09/biotechnology-stocks/printBiotechs Bounce After Three Day Slide:
http://www.reuters.com/assets/print?aid=USL1N0RH22S20140916